0.08 0.003 (4.12%) | 04-25 12:45 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.4 | 1-year : | 0.61 |
Resists | First : | 0.34 | Second : | 0.52 |
Pivot price | 0.21 | |||
Supports | First : | 0.05 | Second : | 0.04 |
MAs | MA(5) : | 0.07 | MA(20) : | 0.27 |
MA(100) : | 1.09 | MA(250) : | 5.51 | |
MACD | MACD : | -0.2 | Signal : | -0.2 |
%K %D | K(14,3) : | 5.3 | D(3) : | 3.4 |
RSI | RSI(14): 20.2 | |||
52-week | High : | 23.39 | Low : | 0.05 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MOTS ] has closed above bottom band by 30.2%. Bollinger Bands are 38.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.11 - 0.11 | 0.11 - 0.11 |
Low: | 0.05 - 0.05 | 0.05 - 0.05 |
Close: | 0.08 - 0.08 | 0.08 - 0.08 |
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Thu, 18 Apr 2024
Motus GI to Release Third Quarter 2020 Results and Provide a Business Update on November 12 - The Globe and Mail
Thu, 18 Apr 2024
Motus GI to Participate in Two Upcoming Investor Conferences in March 2021 - The Globe and Mail
Fri, 05 Apr 2024
If You Had Bought Motus GI Holdings (NASDAQ:MOTS) Stock A Year Ago, You'd Be Sitting On A 68% Loss, Today - Yahoo New Zealand News
Mon, 18 Mar 2024
Motus Gi Holdings Unveils Informal Financial Update - TipRanks.com - TipRanks
Thu, 22 Feb 2024
Motus GI Holdings Strikes Deal to Enhance Capital Flexibility - TipRanks.com - TipRanks
Thu, 22 Feb 2024
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 5 (M) |
Held by Insiders | 4.97e+006 (%) |
Held by Institutions | 1.1 (%) |
Shares Short | 81 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.146e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -6 % |
Return on Assets (ttm) | 232.8 % |
Return on Equity (ttm) | -59.9 % |
Qtrly Rev. Growth | 319000 % |
Gross Profit (p.s.) | -32.02 |
Sales Per Share | -352.21 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -15.9 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -11 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | -0.01 |
Price to Cash Flow | 0.06 |
Dividend | 0 |
Forward Dividend | 23240 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |